In conclusion, this study suggests that IGF-1R, EGFR, and cigarette smoking can be used as additional prognostic factors to the previously known prognostic factors in gastric cancer patients treated with chemoradiation therapy. This evidence concerns the gene EGFR and gastric cancer.